These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26438720)

  • 1. Incorporating an Exercise Detection, Grading, and Hormone Dosing Algorithm Into the Artificial Pancreas Using Accelerometry and Heart Rate.
    Jacobs PG; Resalat N; El Youssef J; Reddy R; Branigan D; Preiser N; Condon J; Castle J
    J Diabetes Sci Technol; 2015 Oct; 9(6):1175-84. PubMed ID: 26438720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
    Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
    J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles.
    Riddell MC; Zaharieva DP; Yavelberg L; Cinar A; Jamnik VK
    J Diabetes Sci Technol; 2015 Oct; 9(6):1217-26. PubMed ID: 26428933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Detection of Physical Activity for People With Type 1 Diabetes Mellitus.
    Dasanayake IS; Bevier WC; Castorino K; Pinsker JE; Seborg DE; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2015 Jun; 9(6):1236-45. PubMed ID: 26134831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
    Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
    J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Physical Activity: Information to Artificial Pancreas Control Systems in Real Time.
    Turksoy K; Paulino TM; Zaharieva DP; Yavelberg L; Jamnik V; Riddell MC; Cinar A
    J Diabetes Sci Technol; 2015 Oct; 9(6):1200-7. PubMed ID: 26443291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
    Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
    J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes.
    Dadlani V; Levine JA; McCrady-Spitzer SK; Dassau E; Kudva YC
    J Diabetes Sci Technol; 2015 Oct; 9(6):1208-16. PubMed ID: 26481641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
    Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
    J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.
    Russell SJ; El-Khatib FH; Nathan DM; Damiano ER
    J Diabetes Sci Technol; 2010 Nov; 4(6):1288-304. PubMed ID: 21129323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated multivariable artificial pancreas control system.
    Turksoy K; Quinn LT; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.
    Ben Brahim N; Place J; Renard E; Breton MD
    J Diabetes Sci Technol; 2015 Oct; 9(6):1185-91. PubMed ID: 26481644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.
    Peters TM; Haidar A
    Diabet Med; 2018 Apr; 35(4):450-459. PubMed ID: 29337384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control to range for diabetes: functionality and modular architecture.
    Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
    J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.